Reata Pharmaceuticals - RETA Stock Reddit Activity & Social Media Sentiment

Disclaimer: high risk play similar in every aspect to an Earnings event. ​ Reata $RETA is a pharma company in the CNS space, currently waiting for PDUFA approval from FDA, expected before 28th February. The CNS is a particularly difficult space for biotech …

RETA stock at $48 a share has calls and puts over $15 each side for exp this month. This is due to the "possibility" of an FDA decision that might come in the next few weeks. Anyone playing this, selling credit spreads for value decay? Risky, but a big payout …

Disclaimer: high risk play similar in every aspect to an Earnings event. ​ Reata $RETA is a pharma company in the CNS space, currently waiting for PDUFA approval from FDA, expected before 28th February. The CNS is a particularly difficult space for biotech …

Many of you complained I didnt share my prior DD in advance for MDGL back to Feb 28, 2023. As luck would have it the company trades monthly options, which expire Feb 17 and March 17th. The play here is not whether the drug will get approval, but rather the FDA …